Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...
Bernstein analyst Florent Cespedes maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €114.00. The ...
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).
The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Michel Robidoux, ...
Researchers discovered that chronic intermittent ... Type 1 Diabetes: Hybrid Closed-Loop and Open-Loop Systems Compared Feb. 12, 2025 — People with type 1 diabetes require continuous insulin ...
Artificial Kidney Market Report Introduction 2 Artificial Kidney Market Executive Summary 3 Competitive Landscape ...
Intermittent fasting may benefit people with type 2 diabetes. Many people believe that intermittent fasting can aid weight loss and offer other health benefits. This article examines whether this ...
hku.hk Objective Whether varying degrees of glycaemic control impact colonic neoplasm risk in patients with diabetes mellitus (DM ... Springbank Pharmaceuticals, Sysmex, Roche and is an advisory board ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...
Most outdoor brand logos are bland as a soggy sandwich left out in the rain. But not Patagonia's. Their logo is like a breath of fresh mountain air in a world of corporate stuffiness. I remember the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results